Dirk Brockstedt

Dirk Brockstedt

Company: RAPT Therapeutics

Job title: Chief Scientific Officer


Modelling Selective Targeting of Treg in the Tumor Microenvironment to Address a Dominant Immune Resistance Mechanism to Current Immunotherapies 12:00 pm

Discuss the role of Treg in immune resistance mechanisms to checkpoint inhibitors and cell therapies The role of CCR4 in the recruitment and accumulation of Treg in the tumor microenvironment Selectively target Treg within the TME while sparing Treg in the periphery and healthy organs Discuss the development of FLX475, a selective, potent, oral, small…Read more

day: Day One Track A AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.